Trustees of Dartmouth College

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

1 drugs in development

Phase 11

By Therapeutic Area

top 0

No TA breakdown available.

R&D Momentum

58/100

Pipeline Velocity

34/100

Trial Completion Rate

100/100

Pipeline Concentration

100/100

Pipeline Freshness

88/100

Activity

Recent Activity

Last 14 days

Nov 5, 2026

Active, not recruiting

The BASIC Trial: Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection

Oct 24, 2026

Completed

MOms in REcovery (MORE): Defining Optimal Care for Pregnant Women and Infants

Earlier

Oct 20, 2026TrialA Randomized Controlled Trial of a College Human Physiology Course With Integrated Mindfulness Practice on Student Applied and Trait Mindfulness, Well-being, and Physiological Stress Reactivity (2026)

Oct 16, 2026TrialCharacterizing the Relationships of Genetic Risk and Parental Coercive Feeding Practices With Appetitive Traits and Adiposity Gain Across Early Life.

Oct 16, 2026TrialUser-Centered Development of an App-Based Cognitive-Behavioral Intervention to Reduce Persistent Opioid Use and Opioid Related Problems Following Spine Surgery

Oct 9, 2026TrialComparing the Impact of Video Integration to Traditional Amyotrophic Lateral Sclerosis Visit Communication on Patient and Caregiver Quality of Life

Oct 8, 2026TrialInteractions Between Placebo Effects and Mindful Awareness State

Oct 8, 2026TrialTranscranial Direct Current Stimulation and Modulation of Affect and Pain

4 more events

Sep 29, 2026TrialDeveloping a Hybrid Type 1 Effectiveness-Implementation Randomized Controlled Trial to Test a Table-Top Water Pitcher to Reduce Arsenic Exposure in Northern New England

Sep 1, 2026TrialThe Role of the Opioid System in Placebo Effects on Pain and Social Rejection

Aug 29, 2026TrialInvestigating Information Preferences, Risk Perceptions, and Tradeoffs in Multi-Cancer Early Detection Decisions: A Randomized Vignette Trial

Aug 19, 2026TrialAdapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by Per- and Polyfluoroalkyl Substances (PFAS)

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Unknown / Other

Placebo Effect

Control Cream with Naloxone

Unknown / Other

Placebo Effect

Control Cream with NaloxonePhase 1

Regulatory

Regulatory Timeline

19912 events

FDAJan 17

Ganite — GANITE

Application NDA019961 (NDA)

FDAJan 17

Ganite — GANITE

Application NDA019961 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)